Lv4
454 积分 2025-05-27 加入
ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy
25天前
已完结
Exploring the design space for Triton X‐100 substitutes in viral inactivation applications
2个月前
已完结
A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates
3个月前
已完结
Vaccination of Glioma Patients with Fusions of Dendritic and Glioma Cells and Recombinant Human Interleukin 12
3个月前
已完结
Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanoma
3个月前
已完结
Intraperitoneal Fluid Neopterin, Nitrate, and Tryptophan After Regional Administration of Interleukin-12
3个月前
已完结
Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma
3个月前
已完结
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
3个月前
已关闭
Preclinical development and a phase I trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
3个月前
已完结
皖公网安备34019202002308
